Khiron Receives First Medical Cannabis Prescriptions for UK Patients Participating in Project Twenty21
Khiron Life Sciences Reports 2019 Fiscal Year End Results and Provides Corporate Update English Français
Khiron Granted Approval to Cultivate 9.3 Tons of THC Cannabis, Representing 17 Percent of the Total Allocated Quota for Colombia in 2020
FDA Accepts LEQEMBI® IQLIK Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
FDA Accepts LEQEMBI® IQLIKTM Supplemental Biologics License Application as a Subcutaneous Starting Dose for the Treatment of Early Alzheimer's Disease under Priority Review
Data at 2026 Boswick Burn & Wound Symposium highlight first integrated use of AVITA Medical technologies
CORRECTION - Domestic Metals Engages ICP Securities Inc. for Automated Market Making Services and provides further details on the engagement of Michael Pound
